EUVIMEDEUVIMED entdecken
Open Access

A novel reagent for the screening of Immunoglobulin A ‐deficient blood donors

Naoko Watanabe-Okochi iD, Ayaka Sato, Akira Okuyama, Go Tomiyoshi, Yumi Suzuki, Yukiko Watanabe, Masako Anazawa, Takashige Shimoyamada, Daisuke Takahashi, Takayuki Onodera, Makoto Uchikawa, Shigeki Miyata

Vox Sanguinis · 2026

DOI: 10.1111/vox.70305 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vox Sanguinis, 2026. Verfasst von Naoko Watanabe-Okochi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Kanto-Koshinetsu Block Blood Center, Japanese Red Cross Society, Tokyo, Japan. Hauptthemen laut MEDLINE: IgA Deficiency, Blood Donors, Immunoglobulin A, Donor Selection. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Immunoglobulin A (IgA) deficiency occurs in approximately 1 in 14,000 individuals in Japan. Approximately 32% harbour anti‐IgA, most of which are naturally occurring and rarely cause anaphylaxis, although high‐titre anti‐IgA from alloimmunization can cause severe reactions. A stable supply of IgA‐deficient plasma is essential for minimizing this risk. We therefore developed a novel reagent for large‐scale identification of IgA‐deficient donors. Materials and Methods Four mouse monoclonal anti‐IgA‐producing cell lines were established using the hybridoma method after immunizing mice with IgA protein. Purified antibodies were conjugated to carboxylate‐modified polystyrene latex beads for IgA measurement using the latex agglutination method on an automated analyser. Samples with low IgA concentrations were re‐tested by enzyme‐linked immunosorbent assay (ELISA) for confirmation. Results Adoption of a dual antibody assay design achieved a detection limit of 0.4 mg/dL, suitable for high‐throughput screening. Screening of 24,977 randomly selected donor samples between February 2022 and April 2023 yielded 4 low IgA cases. IgA deficiency was verified by supplemental ELISA, which was required solely for these four samples. Three of four had IgA levels

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IgA DeficiencyBlood DonorsImmunoglobulin ADonor SelectionHumansAnimalsMiceEnzyme-Linked Immunosorbent AssayBlood DonationAntibodies, MonoclonalJapanAntibodies, Anti-Idiotypic

Stichwörter der Autor:innen

IgA‐deficient donoranti‐IgAreagent for screening

Substanzen

Immunoglobulin AAntibodies, MonoclonalAntibodies, Anti-Idiotypic

Autor:innen und Institutionen

  • Kanto-Koshinetsu Block Blood Center, Japanese Red Cross Society, Tokyo, Japan.
  • Fujikura Kasei Co., Ltd., Tokyo, Japan.
  • Central Blood Institute, Japanese Red Cross Society, Tokyo, Japan.

ORCID-Profile: Naoko Watanabe-Okochi

Zitieren

APA

Watanabe-Okochi, N., Sato, A., Okuyama, A., Tomiyoshi, G., Suzuki, Y., Watanabe, Y., Anazawa, M., Shimoyamada, T., Takahashi, D., Onodera, T., Uchikawa, M., & Miyata, S. (2026). A novel reagent for the screening of Immunoglobulin A ‐deficient blood donors. Vox Sanguinis. https://doi.org/10.1111/vox.70305

Vancouver

Watanabe-Okochi N, Sato A, Okuyama A, Tomiyoshi G, Suzuki Y, Watanabe Y, et al. A novel reagent for the screening of Immunoglobulin A ‐deficient blood donors. Vox Sanguinis. 2026. doi:10.1111/vox.70305

BibTeX
@article{WatanabeOkochi2026,
  author = {Watanabe-Okochi, Naoko and Sato, Ayaka and Okuyama, Akira and Tomiyoshi, Go and Suzuki, Yumi and Watanabe, Yukiko and Anazawa, Masako and Shimoyamada, Takashige and Takahashi, Daisuke and Onodera, Takayuki and Uchikawa, Makoto and Miyata, Shigeki},
  title = {A novel reagent for the screening of Immunoglobulin A ‐deficient blood donors},
  journal = {Vox Sanguinis},
  year = {2026},
  doi = {10.1111/vox.70305}
}
Kostenlos starten →